Collaborative Research, Inc.
United StatesFDA applicant, unverified
- Devices
- 2
What Collaborative Research, Inc. makes
Collaborative Research, Inc. manufactures diagnostic tests for serum complement activity and thyroxine levels in blood samples, used to assess immune function and thyroid hormone levels.
These products are classified as Class II medical devices under FDA regulations and are listed via the 510(k) pathway. The company operates from the United States.
Catalogue
Serum Complement Activity Test-Scat Ref K841541
Regimes: 510(k) Registry: 510(k)Thyroxine Emia Ref K840241
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Collaborative Research, Inc. have in the registry?
The registry currently lists 2 devices for Collaborative Research, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Collaborative Research, Inc.'s devices?
Among its 2 most recently registered devices, Collaborative Research, Inc. has devices listed in FDA 510(k) (2 devices).
What risk classes do Collaborative Research, Inc.'s devices fall under?
Among its 2 most recently registered devices, the classes recorded for Collaborative Research, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Collaborative Research, Inc. in the registry?
The most recently registered devices listed for Collaborative Research, Inc. include SERUM COMPLEMENT ACTIVITY TEST-SCAT and THYROXINE EMIA.